CardioExchange Archive

November 17th, 2013

Remaking the Heart: Stem Cells, Patches, Scaffolds, and More

Vimal Ramjee, MD

Which advance in regenerative cardiovascular biology has the best chance of being translated into a clinical treatment? A cardiology Fellow ponders cutting-edge science presentations at AHA.13.

---

November 15th, 2013

Hypertension Treatment Algorithm Fills in for Missing Guideline

Larry Husten, PHD

When the AHA and the ACC released four updated clinical guidelines earlier this week, a fifth document, the hypertension guideline, was conspicuous by its absence. According to the AHA and the ACC, the authors of the hypertension document have chosen to publish it independently. (No word has yet emerged about their reasons for doing so […]

---

November 12th, 2013

After Long Wait, Updated U.S. Cardiovascular Guidelines Now Emphasize Risk Instead of Targets

Larry Husten, PHD

Updated cardiovascular health guidelines were released today by  the American Heart Association (AHA) and the American College of Cardiology (ACC). The guidelines are designed to provide primary care physicians with evidence-based expert guidance on cholesterol, obesity, risk assessment, and healthy lifestyle. The new guidelines reinforce many of the same messages from previous guidelines, but also represent […]

---

September 9th, 2013

Nontechnical Skills Matter in the Cardiac Operating Room

Joyce Ann Wahr, M.D. and Harlan M. Krumholz, MD, SM

Joyce A. Wahr discusses the importance of teamwork and communication in performing cardiac surgery, as described in a new AHA scientific statement.

---

August 9th, 2013

The Guidelines are Dead. Long Live the Guidelines.

Larry Husten, PHD

Following the recent surprising announcement that the National Heart, Lung, and Blood Institute would no longer issue guidelines, leaders of the American Heart Association (AHA) and the American College of Cardiology (ACC) have now announced that are “officially assuming the joint governance, management and public distribution” of the enormously influential cardiovascular prevention guidelines, including the much-delayed and much-anticipated hypertension […]

---

August 5th, 2013

Putting the 2013 Heart Failure Guidelines Into Practice

Clyde Yancy, MD, Harlan M. Krumholz, MD, SM and John Ryan, MD

CardioExchange’s Harlan Krumholz and John Ryan interview Clyde W. Yancy, lead member of the ACCF/AHA task force that wrote the 2013 guidelines for management of heart failure. Krumholz and Ryan: What is the biggest challenge to implementing the heart failure guidelines for every patient with heart failure? Yancy: The biggest challenge is no longer in establishing “proof.” […]

---

June 20th, 2013

Hypertension and Cholesterol Guidelines Delayed Again as NHLBI Gets Out of the Guidelines Business

Larry Husten, PHD

The National Heart, Lung and Blood Institute (NHLBI) will no longer issue guidelines, including the much-delayed and much-anticipated hypertension (JNC 8) and cholesterol (ATP 4) guidelines. Instead, the NHLBI will perform systematic evidence reviews that other organizations, including the American Heart Association and the American College of Cardiology, will use as a resource for their own guidelines. The […]

---

January 15th, 2013

Large Meta-Analysis Finds No Harm Associated with Eggs

Larry Husten, PHD

No food has had more ups and downs over the last century or so than the common egg. Following a long period in which eggs were ubiquitous and highly regarded, eggs fell from favor with the rise of concerns over cholesterol. Currently, the American Heart Association recommends that people restrict dietary cholesterol to 300 mg per day, which […]

---

November 23rd, 2012

Undiagnosed Hypertension in Younger Adults

Heather M Johnson, MD, MS

Dr. Johnson answers questions about her research group’s study of undiagnosed hypertension in younger adults.

---

November 7th, 2012

Closing Remarks from AHA

Amit Shah, MD, MSCR

On his return home, a fellow wraps up his AHA.12 experience.

---